Agreement - January 30, 2026
Bavarian Nordic signs distribution agreement with Eurofarma
Bavarian Nordic has announced an agreement with Eurofarma, granting them exclusive rights to sell and distribute Bavarian Nordic’s chikungunya vaccine, CHIKV VLP, in Brazil.
Global report - January 30, 2026
AstraZeneca enhances its weight management portfolio
AstraZeneca has entered a new strategic collaboration agreement with CSPC Pharmaceuticals to advance the development of multiple next-generation therapies for obesity and type 2 diabetes across eight programmes.
Biotech Business - January 26, 2026
Leqembi Iqlik supplemental BLA granted Priority Review by FDA
BioArctic’s partner Eisai has announced that the supplemental Biologics License Application (sBLA) for Leqembi Iqlik subcutaneous autoinjector (SC-AI) as a weekly starting dose has been granted Priority Review by the US Food and Drug Administration (FDA).
CDMO - January 23, 2026
Northern Sweden: Diamyd Medical deepens manufacturing collaboration
Diamyd Medical is taking the next step in a long-term manufacturing collaboration with APL and, in parallel, is initiating a strategic collaboration with NorthX Biologics to further develop and scale the manufacturing of retogatein (rhGAD65) ahead of commercialization.
Collaboration - January 22, 2026
Novo Nordisk enters new phase of partnership with Aspect Biosystems
The two companies are entering a new phase of their partnership to develop advanced cellular medicines for diabetes.
Agreement - January 21, 2026
Sigrid Therapeutics enters collaboration to commercialize SiPore
The company has entered into an exclusive global licensing and research collaboration with a multinational consumer health company to expand the SiPore technology platform into consumer oral health through a partner-led approach.
